NCT07057011View on ClinicalTrials.gov

Therapeutic Outcomes of Selective Serotonin Reuptake Inhibitors and Phosphodiesterase-5 Inhibitors Combination Therapy Versus Monotherapy

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

February 1, 2026

Study Completion Date

February 10, 2026

Conditions
Premature Ejaculation
Interventions
DRUG

Paroxetine 20 Mg Oral Tablet

to compare the safety and efficacy of paroxetine alone versus the combination of paroxetine and sildenafil in Premature Ejaculation Patients with genetic polymorphism in the serotonin transporter gene-linked polymorphic region.

Trial Locations (1)

Unknown

South Valley University Hospital, Qina

All Listed Sponsors
lead

South Valley University

OTHER

NCT07057011 - Therapeutic Outcomes of Selective Serotonin Reuptake Inhibitors and Phosphodiesterase-5 Inhibitors Combination Therapy Versus Monotherapy | Biotech Hunter | Biotech Hunter